Bio
Dr. Katrin J. Svensson is Associate Professor in the Department of Pathology at Stanford University. She is Director of the Stanford Metabolic Core Facility, Co-Director of the Pilot & Feasibility Program, and Affinity Group Leader at the Stanford Diabetes Research Center. She is also an Arc Institute Innovation Investigator, a Weill Cancer Hub West Investigator, and a Victor J. Dzau Emerging Leaders in Health and Medicine Scholar of the National Academy of Medicine.
Dr. Svensson leads a research program focused on the discovery and characterization of peptide hormones and endocrine signaling pathways that regulate metabolism, energy balance, and glucose homeostasis. Her laboratory integrates computational biology, proteomics, biochemistry, human genetics, and in vivo physiology to identify mechanisms underlying obesity, diabetes, and metabolic disease. Her work has uncovered pathways controlling insulin-independent glucose uptake, hepatic nutrient sensing, and appetite regulation, and has established scalable platforms for peptide discovery and ligand-receptor deorphanization. Several discoveries from her laboratory have been patented, licensed, and advanced toward therapeutic development.
Svensson is a standing member of the NIDDK POMD study section, serves as an Associate Editor for Endocrine Reviews and is on the Editorial Board at Diabetes. Dr. Svensson founded the Bay Area Metabolism Meeting (BAMM), an annual forum that brings together investigators across academia to accelerate collaboration and advance metabolism research. She is also a co-founder of Merrifield Therapeutics. Her laboratory has been supported by grants from the NIH, American Heart Association, Innovative Medicines Accelerator, Wu Tsai Neuroscience, Weill Cancer Hub, SPARK, SDRC, MCHRI, Merck, Eli Lilly, and Pfizer.
